loading
전일 마감가:
$76.22
열려 있는:
$77.01
하루 거래량:
2.42M
Relative Volume:
0.54
시가총액:
$45.24B
수익:
$5.54B
순이익/손실:
$4.18B
주가수익비율:
11.01
EPS:
7
순현금흐름:
$623.10M
1주 성능:
+1.29%
1개월 성능:
+2.05%
6개월 성능:
+6.96%
1년 성능:
-11.44%
1일 변동 폭
Value
$76.31
$78.75
1주일 범위
Value
$74.20
$78.75
52주 변동 폭
Value
$58.93
$95.25

에드워즈라이프사이언시스 Stock (EW) Company Profile

Name
명칭
Edwards Lifesciences Corp
Name
전화
(949) 250-2500
Name
주소
ONE EDWARDS WAY, IRVINE, CA
Name
직원
15,800
Name
트위터
@edwardslifesci
Name
다음 수익 날짜
2025-02-11
Name
최신 SEC 제출 서류
Name
EW's Discussions on Twitter

EW을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
EW
Edwards Lifesciences Corp
77.13 45.66B 5.54B 4.18B 623.10M 7.00
Medical Devices icon
ABT
Abbott Laboratories
133.02 235.23B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.77 157.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
382.14 148.87B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
81.93 110.72B 33.54B 4.66B 5.19B 3.62

에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-24 업그레이드 Piper Sandler Neutral → Overweight
2025-01-30 업그레이드 Stifel Hold → Buy
2025-01-16 다운그레이드 Wolfe Research Peer Perform → Underperform
2024-12-16 업그레이드 BofA Securities Neutral → Buy
2024-10-11 재개 Morgan Stanley Equal-Weight
2024-09-18 다운그레이드 Jefferies Buy → Hold
2024-07-31 업그레이드 Daiwa Securities Neutral → Outperform
2024-07-29 업그레이드 Wolfe Research Underperform → Peer Perform
2024-07-25 다운그레이드 BofA Securities Buy → Neutral
2024-07-25 다운그레이드 JP Morgan Overweight → Neutral
2024-07-25 다운그레이드 Robert W. Baird Outperform → Neutral
2024-07-25 다운그레이드 TD Cowen Buy → Hold
2024-07-25 다운그레이드 Truist Buy → Hold
2024-05-30 개시 Goldman Buy
2024-05-22 업그레이드 Citigroup Neutral → Buy
2024-05-14 업그레이드 Deutsche Bank Hold → Buy
2024-03-07 업그레이드 BofA Securities Neutral → Buy
2024-02-02 업그레이드 Wells Fargo Equal Weight → Overweight
2024-01-04 다운그레이드 Evercore ISI Outperform → In-line
2023-12-11 다운그레이드 Citigroup Buy → Neutral
2023-11-28 다운그레이드 Wolfe Research Peer Perform → Underperform
2023-09-26 업그레이드 Oppenheimer Perform → Outperform
2023-07-19 개시 Robert W. Baird Outperform
2023-05-30 재개 Morgan Stanley Overweight
2023-03-29 개시 UBS Neutral
2023-03-08 다운그레이드 Wells Fargo Overweight → Equal Weight
2023-02-06 다운그레이드 Raymond James Outperform → Mkt Perform
2023-01-31 다운그레이드 Bernstein Outperform → Underperform
2023-01-30 다운그레이드 Piper Sandler Overweight → Neutral
2022-12-06 다운그레이드 Stifel Buy → Hold
2022-10-28 다운그레이드 Oppenheimer Outperform → Perform
2022-10-26 개시 Mizuho Buy
2022-10-18 개시 Barclays Overweight
2022-10-12 개시 Jefferies Buy
2022-07-29 다운그레이드 Canaccord Genuity Buy → Hold
2022-04-13 개시 Truist Buy
2022-04-06 개시 Wolfe Research Outperform
2022-03-16 업그레이드 Bernstein Mkt Perform → Outperform
2022-03-02 재개 BofA Securities Neutral
2022-02-02 업그레이드 UBS Neutral → Buy
2022-01-27 재확인 Citigroup Buy
2022-01-27 재확인 Evercore ISI Outperform
2022-01-27 재확인 Raymond James Outperform
2022-01-27 재확인 Stifel Buy
2022-01-27 재확인 UBS Neutral
2021-12-17 업그레이드 JP Morgan Neutral → Overweight
2021-12-15 업그레이드 Citigroup Neutral → Buy
2021-12-10 개시 RBC Capital Mkts Outperform
2021-12-06 업그레이드 Wells Fargo Equal Weight → Overweight
2021-07-30 재확인 Canaccord Genuity Buy
2021-07-30 재확인 Deutsche Bank Hold
2021-07-30 재확인 Jefferies Buy
2021-07-30 재확인 Morgan Stanley Overweight
2021-07-30 재확인 Oppenheimer Outperform
2021-07-30 재확인 Stifel Buy
2021-07-30 재확인 UBS Neutral
2021-07-30 재확인 Wells Fargo Equal Weight
2021-05-25 개시 Barclays Overweight
2021-04-15 개시 Atlantic Equities Neutral
2021-04-05 업그레이드 Evercore ISI In-line → Outperform
2020-12-16 다운그레이드 Citigroup Buy → Neutral
2020-12-11 재확인 Canaccord Genuity Buy
2020-09-11 개시 Wolfe Research Underperform
2020-04-28 다운그레이드 Wells Fargo Overweight → Equal Weight
2020-04-17 업그레이드 SVB Leerink Mkt Perform → Outperform
2020-03-05 개시 Citigroup Buy
2020-02-13 개시 Goldman Neutral
2020-02-06 재개 BTIG Research Neutral
2020-01-10 개시 Oppenheimer Outperform
2020-01-02 다운그레이드 Evercore ISI Outperform → In-line
2019-10-24 재확인 Canaccord Genuity Buy
2019-09-23 개시 Piper Jaffray Overweight
2019-07-24 재확인 BofA/Merrill Buy
2019-03-18 재확인 Canaccord Genuity Buy
2019-01-18 업그레이드 BofA/Merrill Neutral → Buy
2019-01-03 개시 Deutsche Bank Hold
2018-11-28 개시 UBS Neutral
2018-10-16 개시 Barclays Underweight
2018-10-02 다운그레이드 BofA/Merrill Buy → Neutral
2018-10-02 다운그레이드 Guggenheim Buy → Neutral
모두보기

에드워즈라이프사이언시스 주식(EW)의 최신 뉴스

pulisher
08:15 AM

Edwards Lifesciences stock rises following competitor’s exit - Investing.com

08:15 AM
pulisher
May 24, 2025

Edwards Lifesciences’ SWOT analysis: stock poised for growth amid market expansion - Investing.com

May 24, 2025
pulisher
May 23, 2025

Edwards' data shows benefits of early intervention in aortic stenosis - BioWorld MedTech

May 23, 2025
pulisher
May 23, 2025

Edwards’ study demonstrates value in early aortic stenosis intervention - Yahoo Finance

May 23, 2025
pulisher
May 23, 2025

Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock - Yahoo Finance

May 23, 2025
pulisher
May 22, 2025

Assessing Edwards Lifesciences: Insights From 6 Financial Analysts - Benzinga

May 22, 2025
pulisher
May 22, 2025

Edwards Lifesciences (EW) Receives Price Target Increase from Ci - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Edwards highlights cost savings, improved outcomes with prompt intervention for aortic stenosis - MassDevice

May 22, 2025
pulisher
May 22, 2025

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Citigroup Adjusts Price Target on Edwards Lifesciences to $95 From $84, Maintains Buy Rating - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Citi Raises Price Target for Edwards Lifesciences (EW) to $95 | - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Analyst Elevates Edwards Lifesciences (EW) as Top Pick | EW Stoc - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Analyst Elevates Edwards Lifesciences (EW) as Top Pick | EW Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Citi adds Edwards Lifesciences stock as Top Pick, drops Insulet - Investing.com

May 22, 2025
pulisher
May 21, 2025

Edwards Lifesciences Holds 2025 EPS Outlook Despite Tariff Headwind - insights.citeline.com

May 21, 2025
pulisher
May 20, 2025

Jim Cramer Notes Edwards Lifesciences (EW) is in a “Good Zone” - Insider Monkey

May 20, 2025
pulisher
May 18, 2025

Edwards Gets FDA Approval for its Next-Generation TAVR Device - Medical Product Outsourcing

May 18, 2025
pulisher
May 16, 2025

Should Edwards Lifesciences Stock Remain in Your Portfolio Now? - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Movers & Shakers: Grant Thornton, United Drug, Edwards Lifesciences, Fine Grain, Viatel, Kepak, EU Commission - Business Post

May 15, 2025
pulisher
May 14, 2025

Edwards Lifesciences Completes Sale of Critical Care - Quantisnow

May 14, 2025
pulisher
May 14, 2025

Do Wall Street Analysts Like Edwards Lifesciences Stock? - Nasdaq

May 14, 2025
pulisher
May 13, 2025

Edwards Lifesciences (EW) Sees Price Target Increase Amid Regula - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Edwards Lifesciences at BofA Conference: Strong Growth Amid Challenges By Investing.com - Investing.com Canada

May 13, 2025
pulisher
May 13, 2025

Edwards Lifesciences (EW) Sees Price Target Increase by Piper Sa - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Edwards Lifesciences at BofA Conference: Strong Growth Amid Challenges - Investing.com

May 13, 2025
pulisher
May 13, 2025

Piper Sandler Adjusts Price Target on Edwards Lifesciences to $83 From $80, Maintains Overweight Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Piper Sandler raises Edwards Lifesciences target to $83 - Investing.com

May 13, 2025
pulisher
May 12, 2025

FDA Clears New Indication for Edwards’ Sapien 3 - Orange County Business Journal

May 12, 2025
pulisher
May 09, 2025

Why Edwards Lifesciences (EW) Is Among the Best Medical Device Stocks to Buy Now - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

Edwards Lifesciences Corporation (EW) Announces Amendments to Employee Stock Purchase Plans - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insigh - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Edwards Lifesciences First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

May 08, 2025
pulisher
May 06, 2025

Edwards Lifesciences CEO and CFO Set for Exclusive Fireside Chat at Major BofA Healthcare Conference - Stock Titan

May 06, 2025
pulisher
May 02, 2025

Edwards Lifesciences (NYSE:EW) Receives FDA Approval For Groundbreaking TAVR Therapy For Asymptomatic Patients - Yahoo Finance

May 02, 2025
pulisher
May 01, 2025

Edwards Lifesciences Gets FDA Approval for TAVR in Asymptomatic Aortic Stenosis - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

Edwards wins FDA nod for TAVR in aortic stenosis without symptoms - MassDevice

May 01, 2025
pulisher
May 01, 2025

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis - BioSpace

May 01, 2025
pulisher
May 01, 2025

FDA approves Edwards Lifesciences’ TAVR therapy By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

FDA approves Edwards Lifesciences’ TAVR therapy - Investing.com

May 01, 2025
pulisher
Apr 30, 2025

Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite? - Insider Monkey

Apr 30, 2025
pulisher
Apr 28, 2025

Commit To Purchase Edwards Lifesciences At $60, Earn 6.8% Using Options - Nasdaq

Apr 28, 2025
pulisher
Apr 26, 2025

Edwards Lifesciences Corporation (NYSE:EW) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 26, 2025
pulisher
Apr 25, 2025

Edwards Lifesciences Reports Robust Q1 2025 Growth - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

Edwards Lifesciences (EW) Price Target Raised by Canaccord Analy - GuruFocus

Apr 25, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences Raises 2025 Sales Forecast Amid Currency Boost - Finimize

Apr 24, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook BrightensEdwards Lifesciences (NYSE:EW) - Benzinga

Apr 24, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences (NYSE:EW) Projects 2025 Sales Over US$5.7 Billion With Strong Earnings - Yahoo Finance

Apr 24, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences Corp (EW) Shares Up 7.25% on Apr 24 - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga

Apr 24, 2025
pulisher
Apr 24, 2025

Stifel maintains Edwards Lifesciences stock with $90 target - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Bernstein Adjusts Price Target on Edwards Lifesciences to $80 From $78 - marketscreener.com

Apr 24, 2025

에드워즈라이프사이언시스 (EW) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$85.33
price up icon 0.97%
$71.01
price up icon 2.67%
medical_devices SNN
$28.70
price down icon 0.03%
medical_devices STE
$245.50
price up icon 1.08%
$326.64
price up icon 1.64%
자본화:     |  볼륨(24시간):